Media Summary: Rep. Cindy Ryu (WA), Dr. Debra Patt and Hilary Gee Goeckner discuss the growing impact of Hear from cancer survivors, legislators and During this session of the 2023 Joint HPVRT/NRTCC National Meeting, we discovered how

Acs Can Nbcsl Briefing On Biomarker Testing And Health Equity - Detailed Analysis & Overview

Rep. Cindy Ryu (WA), Dr. Debra Patt and Hilary Gee Goeckner discuss the growing impact of Hear from cancer survivors, legislators and During this session of the 2023 Joint HPVRT/NRTCC National Meeting, we discovered how On July 23, 2021, the American Cancer Society To help reduce the unequal burden of cancer in diverse communities, the American Cancer Society's As the need for access to guideline-concordant

Josh was diagnosed with colon cancer when he was only 34 years old. But thanks to treatment enabled by

Photo Gallery

ACS CAN/NBCSL Briefing on Biomarker Testing and Health Equity
Women in Government and ACS CAN Biomarker Testing Briefing
Biomarker Testing Advocacy
CA Cancer Caucus Legislative Briefing on Biomarker Testing
Improving Access to Biomarker Testing in Illinois
Biomarker Testing: Unlocking Personalized Treatments to Improve Patient Outcomes
Impact of Biomarker Testing on Cancer Patients
ACS CAN’s Work to Advance Health Equity
The National Islands: Centering Health Equity Session
Medicaid & Health Equity: 100 Years After the Tulsa Race Massacre
American Cancer Society Health Equity Ambassadors
Policy Perspectives on Biomarker Testing Coverage for 2024
Sponsored
Sponsored
View Detailed Profile
ACS CAN/NBCSL Briefing on Biomarker Testing and Health Equity

ACS CAN/NBCSL Briefing on Biomarker Testing and Health Equity

ACS CAN

Women in Government and ACS CAN Biomarker Testing Briefing

Women in Government and ACS CAN Biomarker Testing Briefing

Rep. Cindy Ryu (WA), Dr. Debra Patt and Hilary Gee Goeckner discuss the growing impact of

Sponsored
Biomarker Testing Advocacy

Biomarker Testing Advocacy

Biomarker testing

CA Cancer Caucus Legislative Briefing on Biomarker Testing

CA Cancer Caucus Legislative Briefing on Biomarker Testing

The CA Cancer Caucus held a Legislative

Improving Access to Biomarker Testing in Illinois

Improving Access to Biomarker Testing in Illinois

Hear from cancer survivors, legislators and

Sponsored
Biomarker Testing: Unlocking Personalized Treatments to Improve Patient Outcomes

Biomarker Testing: Unlocking Personalized Treatments to Improve Patient Outcomes

Biomarker testing

Impact of Biomarker Testing on Cancer Patients

Impact of Biomarker Testing on Cancer Patients

Biomarker testing

ACS CAN’s Work to Advance Health Equity

ACS CAN’s Work to Advance Health Equity

Watch

The National Islands: Centering Health Equity Session

The National Islands: Centering Health Equity Session

During this session of the 2023 Joint HPVRT/NRTCC National Meeting, we discovered how

Medicaid & Health Equity: 100 Years After the Tulsa Race Massacre

Medicaid & Health Equity: 100 Years After the Tulsa Race Massacre

On July 23, 2021, the American Cancer Society

American Cancer Society Health Equity Ambassadors

American Cancer Society Health Equity Ambassadors

To help reduce the unequal burden of cancer in diverse communities, the American Cancer Society's

Policy Perspectives on Biomarker Testing Coverage for 2024

Policy Perspectives on Biomarker Testing Coverage for 2024

As the need for access to guideline-concordant

ACS Mission & Health Equity Partnership Promo

ACS Mission & Health Equity Partnership Promo

ACS

Biomarker Testing in Arizona

Biomarker Testing in Arizona

In 2022,

Empowering Change: ACS NRTCC's Commitment to Health Equity

Empowering Change: ACS NRTCC's Commitment to Health Equity

ACS

Biomarker Testing: A Vital Step in Equitable Lung Cancer Care

Biomarker Testing: A Vital Step in Equitable Lung Cancer Care

Healthcare

Health Equity: Closing the Gap

Health Equity: Closing the Gap

Join

Jen's Biomarker Story

Jen's Biomarker Story

After a shocking lung cancer diagnosis,

Medicaid & COVID-19 Through the Health Equity Lens

Medicaid & COVID-19 Through the Health Equity Lens

View highlights from an

Josh's Biomarker Story

Josh's Biomarker Story

Josh was diagnosed with colon cancer when he was only 34 years old. But thanks to treatment enabled by